Severe SARS-CoV-2 infection in a 32-week pregnant woman treated with Remdesivir-Dexamethasone combination therapy: A case report.

Seyed Mohammad Amin AlaviSamaneh BahramiMahin NajafianMina Hoori

Published in: Clinical case reports (2022)

This study shows that remdesivir and dexamethasone combination therapy can be considered as a suitable treatment choice for pregnant women infected with COVID-19. It is worth mentioning that more studies are required to evaluate the efficacy and side effects of remdesivir monotherapy and its combination with dexamethasone during pregnancy.

Keyphrases

combination therapy
pregnant women
high dose
low dose
coronavirus disease
sars cov
respiratory syndrome coronavirus
early onset
randomized controlled trial
clinical trial
decision making
case control